Morgan Stanley’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $142K | Buy |
|
|||||
|
2025
Q1 | $108K | Sell |
|
|||||
|
2024
Q4 | $358K | Buy |
|
|||||
|
2024
Q3 | $194K | Buy |
|
|||||
|
2024
Q2 | $161K | Buy |
|
|||||
|
2024
Q1 | $223K | Sell |
|
|||||
|
2023
Q4 | $470K | Buy |
|
|||||
|
2023
Q3 | $107K | Sell |
|
|||||
|
2023
Q2 | $152K | Sell |
|
|||||
|
2023
Q1 | $150K | Buy |
|
|||||
|
2022
Q4 | $156K | Sell |
|
|||||
|
2022
Q3 | $174K | Sell |
|
|||||
|
2022
Q2 | $283K | Buy |
|
|||||
|
2022
Q1 | $374K | Sell |
|
|||||
|
2021
Q4 | $974K | Sell |
|
|||||
|
2021
Q3 | $1.62M | Buy |
|
|||||
|
2021
Q2 | $1.78M | Sell |
|
|||||
|
2021
Q1 | $5.22M | Sell |
|
|||||
|
2020
Q4 | $8.3M | Sell |
|
|||||
|
2020
Q3 | $9.67M | Sell |
|
|||||
|
2020
Q2 | $14.2M | Buy |
|
|||||
|
2020
Q1 | $6.64M | Buy |
|
|||||
|
2019
Q4 | $12.2M | Buy |
|
|||||
|
2019
Q3 | $7.24M | Buy |
|
|||||
|
2019
Q2 | $7.72M | Buy |
|
|||||
|
2019
Q1 | $5.79M | Sell |
|
|||||
|
2018
Q4 | $5.58M | Sell |
|
|||||
|
2018
Q3 | $13.6M | Buy |
|
|||||
|
2018
Q2 | $10.9M | Buy |
|
|||||
|
2018
Q1 | $7.97M | Sell |
|
|||||
|
2017
Q4 | $14.5M | Buy |
|
|||||
|
2017
Q3 | $4.93M | Buy |
|
|||||
|
2017
Q2 | $1.88M | Buy |
|
|||||
|
2017
Q1 | $835K | Sell |
|
|||||
|
2016
Q4 | $1.19M | Buy |
|
|||||
|
2016
Q3 | $1.56M | Buy |
|
|||||
|
2016
Q2 | $152K | Buy |
|
|||||
|
2016
Q1 | $122K | Sell |
|
|||||
|
2015
Q4 | $146K | Sell |
|
|||||
|
2015
Q3 | $124K | Sell |
|
|||||
|
2015
Q2 | $419K | Buy |
|
|||||
|
2015
Q1 | $17K | Buy |
|